Based on surveyor observation, clinical record review, and staff interview, it has been determined that the facility failed to ensure a resident's drug regimen is free from unnecessary drugs for 1 of 2 residents reviewed for the use of psychotropic medications without adequate indication of use, Resident ID #8. Findings are as follows:Record review revealed the resident was admitted to the facility in September of 2025 with a diagnosis including, but not limited to, dementia without behavioral disturbance, psychotic mood disturbance, or anxiety.Record review revealed the following physician's orders: -Lexapro (a medication prescribed to treat used to treat depression and anxiety disorder) 10 milligrams (mg) tablet once daily initiated on 3/30/2026. …
F605 citations in Rhode Island
Freedom from Abuse, Neglect, and Exploitation Deficiencies
Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
Rhode Island cites F605 less often than its own record predicts
0.74 times the national share — cited less often here than elsewhere.
Of every deficiency written in Rhode Island in 2025, this is the portion that was F605.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Rhode Island surveyors wrote
F605 findings written in Rhode Island, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
What else Rhode Island surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction